Global Akkermansia Probiotic Market Growth 2025-2031
Description
The global Akkermansia Probiotic market size is predicted to grow from US$ 350 million in 2025 to US$ 638 million in 2031; it is expected to grow at a CAGR of 10.5% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Akkermansia probiotic refers to supplements containing Akkermansia muciniphila, a beneficial gut bacterium known for supporting intestinal health and metabolic balance. Naturally found in the human gut, this microbe feeds on mucin (a component of the gut lining) and helps maintain the integrity of the intestinal barrier, reduce inflammation, and regulate body weight and glucose metabolism. Emerging research suggests that Akkermansia may be beneficial for individuals with obesity, type 2 diabetes, or inflammatory bowel conditions. While not yet as widely available as other probiotics, pasteurized or next-generation forms of Akkermansia are being developed for use in dietary supplements and functional foods.
United States market for Akkermansia Probiotic is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Akkermansia Probiotic is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Akkermansia Probiotic is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Akkermansia Probiotic players cover IFF Health Sciences, Shanenkang Biotechnology, Sacco System, Wecare Probiotics, TIME International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Akkermansia Probiotic Industry Forecast” looks at past sales and reviews total world Akkermansia Probiotic sales in 2024, providing a comprehensive analysis by region and market sector of projected Akkermansia Probiotic sales for 2025 through 2031. With Akkermansia Probiotic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Akkermansia Probiotic industry.
This Insight Report provides a comprehensive analysis of the global Akkermansia Probiotic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Akkermansia Probiotic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Akkermansia Probiotic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Akkermansia Probiotic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Akkermansia Probiotic.
This report presents a comprehensive overview, market shares, and growth opportunities of Akkermansia Probiotic market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
100-200 BCFU/g
200-300 BCFU/g
Others
Segmentation by Application:
Supplements
Special Medical Foods
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
IFF Health Sciences
Shanenkang Biotechnology
Sacco System
Wecare Probiotics
TIME International
Key Questions Addressed in this Report
What is the 10-year outlook for the global Akkermansia Probiotic market?
What factors are driving Akkermansia Probiotic market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Akkermansia Probiotic market opportunities vary by end market size?
How does Akkermansia Probiotic break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Akkermansia probiotic refers to supplements containing Akkermansia muciniphila, a beneficial gut bacterium known for supporting intestinal health and metabolic balance. Naturally found in the human gut, this microbe feeds on mucin (a component of the gut lining) and helps maintain the integrity of the intestinal barrier, reduce inflammation, and regulate body weight and glucose metabolism. Emerging research suggests that Akkermansia may be beneficial for individuals with obesity, type 2 diabetes, or inflammatory bowel conditions. While not yet as widely available as other probiotics, pasteurized or next-generation forms of Akkermansia are being developed for use in dietary supplements and functional foods.
United States market for Akkermansia Probiotic is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Akkermansia Probiotic is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Akkermansia Probiotic is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Akkermansia Probiotic players cover IFF Health Sciences, Shanenkang Biotechnology, Sacco System, Wecare Probiotics, TIME International, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Akkermansia Probiotic Industry Forecast” looks at past sales and reviews total world Akkermansia Probiotic sales in 2024, providing a comprehensive analysis by region and market sector of projected Akkermansia Probiotic sales for 2025 through 2031. With Akkermansia Probiotic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Akkermansia Probiotic industry.
This Insight Report provides a comprehensive analysis of the global Akkermansia Probiotic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Akkermansia Probiotic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Akkermansia Probiotic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Akkermansia Probiotic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Akkermansia Probiotic.
This report presents a comprehensive overview, market shares, and growth opportunities of Akkermansia Probiotic market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
100-200 BCFU/g
200-300 BCFU/g
Others
Segmentation by Application:
Supplements
Special Medical Foods
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
IFF Health Sciences
Shanenkang Biotechnology
Sacco System
Wecare Probiotics
TIME International
Key Questions Addressed in this Report
What is the 10-year outlook for the global Akkermansia Probiotic market?
What factors are driving Akkermansia Probiotic market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Akkermansia Probiotic market opportunities vary by end market size?
How does Akkermansia Probiotic break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
85 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Akkermansia Probiotic by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Akkermansia Probiotic by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
